Fund Holdings — venBio Partners LLC

Total Portfolio Value
$216.27M
Total Bought
$0
Total Sold
$3.22M
Net Transaction
-$3.22M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
ALUMIS INC4,619,8034,619,803018,43345,08920.85%+26,656
PHARVARIS N V
COM
4,639,3044,639,3040115,751128,74159.53%+12,990
HARMONY BIOSCIENCES HLDGS IN(HRMY)489,194489,194013,48218,3068.46%+4,823
LYELL IMMUNOPHARMA INC(LYEL)473,479337,697-135,7827,68910,3944.81%+2,705
ARTIVA BIOTHERAPEUTICS INC(ARTV)1,148,975648,507-500,4683,2982,7821.29%-515
ALX ONCOLOGY HLDGS INC(ALXO)9,699,9259,699,925017,75110,9615.07%-6,790
Page 1 of 1
venBio Partners LLC — 13F Holdings — Q4 2025 | TickerTrail